Cargando…

Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study

At present, it has been noticed that some patients recovered from COVID-19 present a recurrent positive RNA test of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) after being discharged from hospitals. The purpose of the current study was to characterize the clinical features of re-hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Lei, Wang, Runsheng, Yu, Na, Hu, Chao, Yan, Junhong, Zhang, Xiaomin, Wang, Tao, Hao, Jungui, Gao, Fuquan, Liu, Tonggang, Wang, Jing, Liu, Xiaojing, Mu, Mi, Huang, Wei, Guo, Yongzhong, Lv, Changjun, Wang, Xiaozhi, Tu, Lei, Wan, Kun, Xu, Guogang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808928/
https://www.ncbi.nlm.nih.gov/pubmed/33447913
http://dx.doi.org/10.1007/s10096-020-04151-9
_version_ 1783637007231090688
author Pan, Lei
Wang, Runsheng
Yu, Na
Hu, Chao
Yan, Junhong
Zhang, Xiaomin
Wang, Tao
Hao, Jungui
Gao, Fuquan
Liu, Tonggang
Wang, Jing
Liu, Xiaojing
Mu, Mi
Huang, Wei
Guo, Yongzhong
Lv, Changjun
Wang, Xiaozhi
Tu, Lei
Wan, Kun
Xu, Guogang
author_facet Pan, Lei
Wang, Runsheng
Yu, Na
Hu, Chao
Yan, Junhong
Zhang, Xiaomin
Wang, Tao
Hao, Jungui
Gao, Fuquan
Liu, Tonggang
Wang, Jing
Liu, Xiaojing
Mu, Mi
Huang, Wei
Guo, Yongzhong
Lv, Changjun
Wang, Xiaozhi
Tu, Lei
Wan, Kun
Xu, Guogang
author_sort Pan, Lei
collection PubMed
description At present, it has been noticed that some patients recovered from COVID-19 present a recurrent positive RNA test of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) after being discharged from hospitals. The purpose of the current study was to characterize the clinical features of re-hospitalized patients with recurrent SARS-CoV-2 positive results. From January 12 to April 1 of 2020, our retrospective study was conducted in China. The exposure history, baseline data, laboratory findings, therapeutic schedule, and clinical endpoints of the patients were collected. All the patients were followed until April 10, 2020. Among all COVID-19 patients included in the current study, there were 14 re-hospitalized patients due to recurrent positive tests of SARS-CoV-2 RNA. Fever (11 [78.6%]), cough (10 [71.4%]), and fatigue (7 [50.0%]) were the most common symptoms on the patient’s first admission, and less symptoms were found on their second admission. The average duration from the onset of symptoms to admission to hospital was found to be 8.4 days for the first admission and 2.6 days for the second admission (P = 0.002). The average time from the detection of RNA (+) to hospitalization was 1.9 days for the first admission and 2.6 days for the second admission (P = 0.479), and the average time from RNA (+) to RNA (−) was 11.1 days for the first admission and 6.3 days for the second admission (P = 0.030). Moreover, the total time in hospital was 18.6 days for the first admission and 8.0 days for the second admission (P = 0.000). It may be necessary to increase the isolation observation time and RT-PCR tests should be timely performed on multiple samples as soon as possible.
format Online
Article
Text
id pubmed-7808928
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-78089282021-01-15 Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study Pan, Lei Wang, Runsheng Yu, Na Hu, Chao Yan, Junhong Zhang, Xiaomin Wang, Tao Hao, Jungui Gao, Fuquan Liu, Tonggang Wang, Jing Liu, Xiaojing Mu, Mi Huang, Wei Guo, Yongzhong Lv, Changjun Wang, Xiaozhi Tu, Lei Wan, Kun Xu, Guogang Eur J Clin Microbiol Infect Dis Original Article At present, it has been noticed that some patients recovered from COVID-19 present a recurrent positive RNA test of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) after being discharged from hospitals. The purpose of the current study was to characterize the clinical features of re-hospitalized patients with recurrent SARS-CoV-2 positive results. From January 12 to April 1 of 2020, our retrospective study was conducted in China. The exposure history, baseline data, laboratory findings, therapeutic schedule, and clinical endpoints of the patients were collected. All the patients were followed until April 10, 2020. Among all COVID-19 patients included in the current study, there were 14 re-hospitalized patients due to recurrent positive tests of SARS-CoV-2 RNA. Fever (11 [78.6%]), cough (10 [71.4%]), and fatigue (7 [50.0%]) were the most common symptoms on the patient’s first admission, and less symptoms were found on their second admission. The average duration from the onset of symptoms to admission to hospital was found to be 8.4 days for the first admission and 2.6 days for the second admission (P = 0.002). The average time from the detection of RNA (+) to hospitalization was 1.9 days for the first admission and 2.6 days for the second admission (P = 0.479), and the average time from RNA (+) to RNA (−) was 11.1 days for the first admission and 6.3 days for the second admission (P = 0.030). Moreover, the total time in hospital was 18.6 days for the first admission and 8.0 days for the second admission (P = 0.000). It may be necessary to increase the isolation observation time and RT-PCR tests should be timely performed on multiple samples as soon as possible. Springer Berlin Heidelberg 2021-01-15 2021 /pmc/articles/PMC7808928/ /pubmed/33447913 http://dx.doi.org/10.1007/s10096-020-04151-9 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Pan, Lei
Wang, Runsheng
Yu, Na
Hu, Chao
Yan, Junhong
Zhang, Xiaomin
Wang, Tao
Hao, Jungui
Gao, Fuquan
Liu, Tonggang
Wang, Jing
Liu, Xiaojing
Mu, Mi
Huang, Wei
Guo, Yongzhong
Lv, Changjun
Wang, Xiaozhi
Tu, Lei
Wan, Kun
Xu, Guogang
Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study
title Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study
title_full Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study
title_fullStr Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study
title_full_unstemmed Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study
title_short Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study
title_sort clinical characteristics of re-hospitalized covid-19 patients with recurrent positive sars-cov-2 rna: a retrospective study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808928/
https://www.ncbi.nlm.nih.gov/pubmed/33447913
http://dx.doi.org/10.1007/s10096-020-04151-9
work_keys_str_mv AT panlei clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT wangrunsheng clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT yuna clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT huchao clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT yanjunhong clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT zhangxiaomin clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT wangtao clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT haojungui clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT gaofuquan clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT liutonggang clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT wangjing clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT liuxiaojing clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT mumi clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT huangwei clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT guoyongzhong clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT lvchangjun clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT wangxiaozhi clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT tulei clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT wankun clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy
AT xuguogang clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy